Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
about
Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized TrialsPharmacologic agents for acute hemodynamic instability: recent advances in the management of perioperative shock- a systematic reviewAcute Kidney Injury Subsequent to Cardiac SurgeryImmediate and Long-Term Outcome of Acute H2S Intoxication Induced Coma in Unanesthetized Rats: Effects of Methylene BlueMethylene blue counteracts H2S toxicity-induced cardiac depression by restoring L-type Ca channel activityVasopressin and methylene blue: alternate therapies in vasodilatory shock.Methylene blue for postcardiopulmonary bypass vasoplegic syndrome: A cohort study.Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study.Venoarterial extracorporeal membrane oxygenation for the management of massive amlodipine overdoseMethylene blue: revisited.Methylene blue modulates transendothelial migration of peripheral blood cells.The values shown on optical technology-based patient monitors must be cautiously interpreted: intravenous dye-induced errors.H2S induced coma and cardiogenic shock in the rat: Effects of phenothiazinium chromophores.Evaluation of the protein biomarkers and the analgesic response to systemic methylene blue in patients with refractory neuropathic pain: a double-blind, controlled studyMethylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass.Short-term beneficial effects of methylene blue on kidney damage in septic shock patients.Neuro- and cardioprotective effects of blockade of nitric oxide action by administration of methylene blue.Methylene blue-induced methemoglobinemia during cardiopulmonary bypass? A case report and literature review.Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium.Methylene blue for the treatment of septic shock.Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.Therapeutic strategies for high-dose vasopressor-dependent shock.Methylene blue for burn-induced vasoplegia: case report and review of literature.Effect of a single bolus of methylene blue prophylaxis on vasopressor and transfusion requirement in infective endocarditis patients undergoing cardiac surgery.Methylene blue treatment for cytokine release syndrome-associated vasoplegia following a renal transplant with rATG infusion: A case report and literature review.Risk assessment and outcomes of vasoplegia after cardiac surgery.Key Points for Curbing Cardiopulmonary Bypass Inflammation.Refractory Vasoplegic Syndrome in an Adult Patient with Infective Endocarditis: A Case Report and Literature Review.Use of methylene blue for treatment of severe sepsis in an immunosuppressed patient after liver transplantation.A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy.A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.Use of methylene blue in the treatment of refractory vasodilatory shock after cardiac assist device implantation: report of four consecutive cases.Pheochromocytoma crisis with severe cyclic blood pressure fluctuations in a cardiac pheochromocytoma patient successfully resuscitated by extracorporeal membrane oxygenation: a case report.Perioperative Diagnosis and Treatment of Serotonin Syndrome Following Administration of Methylene Blue.Very High Dose Epinephrine for the Treatment of Vasoplegic Syndrome during Liver TransplantationTrans-aortic counterpulsation: a viable alternative?Methylene blue used in the treatment of refractory shock resulting from drug poisoning.Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series.Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive Agents Treated with Methylene Blue.The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery.
P2860
Q26777564-E91E0F07-8417-4BA9-B32F-CCBC9371F563Q26781777-54D7C300-47A7-4C88-8606-4BC872F5DB00Q26782703-2EA4B1B2-CA6E-4E5A-BA57-6FB87ABB2E98Q28545836-46690611-F414-4461-98EA-EC79E2FD1EC2Q30781363-FEBD87C0-F5C0-4F38-8C50-6870F644F3B1Q33391378-CDDDD565-A322-45E4-8CAB-67F07D1D3AEAQ33613163-FBF1AFF2-A45C-4198-90BC-7176DFF30E14Q33793231-1CB765B9-1D92-4676-AB19-49CDEB8CC3C4Q34775361-5B93A6A7-4B0F-436B-9137-416BCB01FB57Q34921079-1CFE3859-33C4-4F6C-91E2-93217F876795Q35067725-CFAC884F-D2E3-4AED-884D-232467D4D351Q35258562-A17C3FD9-6BF0-48C2-B6C6-58DF359653BAQ35748428-566C2205-9D04-4E3A-9906-AAFE3ECDD387Q35871768-55D2E5E1-9BFE-44AB-AF0D-9ADA45B0F613Q36140718-88BD641F-DDFA-4879-8D8D-51AA636B516DQ36432124-0CC913E3-6D05-46AD-9CDE-CDE9D9895F33Q37031228-472F5ACE-07F1-447D-85F5-D8CE38E67E9EQ37293431-8D5D3541-5F48-49D9-800D-AE5D08A697C3Q37474062-38F56746-D3E5-40B6-A77A-E352FBBC4948Q37767426-D74FF434-0A96-4894-971D-1E7795B53014Q37959053-0056A9EF-771C-4405-9F38-89CD1B4ED936Q38154892-9D7F8F3D-034F-4B57-B888-7219C93E815DQ38357700-D10D891F-0EBC-42DD-8E42-A65DA71B93A4Q38458772-2FCBF3CC-7568-46D7-A001-0E16D44D8C69Q38542070-F5E4DBD6-0762-4753-A5F0-8D9A39AD6EE7Q38726584-7C0BFA1C-1F0E-416A-A150-795A6B3DAB78Q38824796-3D18FDD1-7118-4EDD-9255-1F8B2B310614Q39282095-D2589390-F97F-43FA-AA13-9B6F44E86431Q41140086-52F3994E-C04E-4D89-9E59-D00C44EE3AA9Q41343209-E1690EFC-2E68-4E05-9BDF-0DC3D970E4CFQ41452877-9D36B9CE-56CF-4C75-8304-79781BA5E4C3Q41985767-55C3EBFF-5AD9-4270-8A87-1364429DC99DQ42004596-D3AC98E9-D7DE-47E6-9108-D4AD9016EB5BQ42569004-1AFC25E4-044F-43C3-88D0-CCF61BF63C32Q42727259-C38AA175-D014-47CF-9DCF-A1883142D280Q43127376-621DD77D-216D-49E0-A238-3044E8CB747DQ45829491-5AD68EEB-D0C2-4A2C-AC0D-464F04E9929FQ46183590-147E484C-974C-4A78-9972-890B5EBA6A2FQ47104290-49037785-D006-4D61-933B-E63C15CAD7A9Q47148759-9D014359-CA16-4F49-9A37-1468BEBBF086
P2860
Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Methylene blue reduces mortali ...... atients after cardiac surgery.
@ast
Methylene blue reduces mortali ...... atients after cardiac surgery.
@en
Methylene blue reduces mortali ...... atients after cardiac surgery.
@nl
type
label
Methylene blue reduces mortali ...... atients after cardiac surgery.
@ast
Methylene blue reduces mortali ...... atients after cardiac surgery.
@en
Methylene blue reduces mortali ...... atients after cardiac surgery.
@nl
prefLabel
Methylene blue reduces mortali ...... atients after cardiac surgery.
@ast
Methylene blue reduces mortali ...... atients after cardiac surgery.
@en
Methylene blue reduces mortali ...... atients after cardiac surgery.
@nl
P2093
P921
P1476
Methylene blue reduces mortali ...... atients after cardiac surgery.
@en
P2093
Carlos D Del Mazo
Daniel J Taborda
Fernando J Boullon
Gustavo F Bruno
Jorge J Griotti
Marcela A Degrange
P304
P356
10.1016/S0003-4975(03)01510-8
P407
P577
2004-02-01T00:00:00Z